SCOPUS 정보 검색 플랫폼

Volumn 2, Issue 4, 2007, Pages 445-448

Slow-, tight-binding HIV-1 reverse transcriptase non-nucleoside inhibitors highly active against drug-resistant mutants

(12) Cancio, Reynel a Mai, Antonello b Rotili, Dante b Artico, Marino b Sbardella, Gianluca c Clotet Codina, Imma d Esté, José A d Crespan, Emmanuele a Zanoli, Samantha a Hübscher, Ulrich e Spadari, Silvio a Maga, Giovanni a

a CNR (Italy)

b SAPIENZA UNIVERSITY OF ROME (Italy)

c UNIVERSITY OF SALERNO (Italy)

d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL (Spain)

e UNIVERSITY OF ZURICH (Switzerland)

Author keywords

Anti HIV 1 agents; Dihydro alkoxy benzyl oxopyrimidines (DABOS); Kinetic analysis; Non nucleoside reverse transcriptase inhibitors (NNRTIs); Slow , tight binding

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL RESISTANCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION; STRUCTURE ACTIVITY RELATION;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; HIV REVERSE TRANSCRIPTASE; HIV-1; MOLECULAR STRUCTURE; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34547939030 PISSN: 18607179 EISSN: 18607187 Source Type: Journal
DOI: 10.1002/cmdc.200600310 Document Type: Article

Times cited : (22)

References (25)

1
- 0033959183
- a) S. Vella, L. Palmisano, Antiviral Res. 2000, 45, 1-7;
- (2000) Antiviral Res , vol.45 , pp. 1-7
- Vella, S.¹ Palmisano, L.²

2
- 0033787277
- b) G. R. Kaufmann, D. A. Cooper, Curr. Opin. Microbiol. 2000, 3, 508-514.
- (2000) Curr. Opin. Microbiol , vol.3 , pp. 508-514
- Kaufmann, G.R.¹ Cooper, D.A.²

3
- 0032437454
- a) E. De Clercq, Antiviral Res. 1998, 38, 153-179;
- (1998) Antiviral Res , vol.38 , pp. 153-179
- De Clercq, E.¹

4
- 12144265244
- b) E. De Clercq, Chem. Biodiversity 2004, 1, 44-64.
- (2004) Chem. Biodiversity , vol.1 , pp. 44-64
- De Clercq, E.¹

5
- 33646848691
- D. C. Meadows, J. Gervay-Hague, ChemMedChem 2006, 1, 16-29.
- (2006) ChemMedChem , vol.1 , pp. 16-29
- Meadows, D.C.¹ Gervay-Hague, J.²

6
- 0036104758
- G. Campiani, A. Ramunno, G. Maga, V. Nacci, C. Fattorusso, B. Catalanotti, E. Morelli, E. Novellino, Curr. Pharm. Des. 2002, 8, 615-657.
- (2002) Curr. Pharm. Des , vol.8 , pp. 615-657
- Campiani, G.¹ Ramunno, A.² Maga, G.³ Nacci, V.⁴ Fattorusso, C.⁵ Catalanotti, B.⁶ Morelli, E.⁷ Novellino, E.⁸

7
- 84885332080
- a) M. Artico, Drugs Future 2002, 27, 159-175;
- (2002) Drugs Future , vol.27 , pp. 159-175
- Artico, M.¹

8
- 0027521797
- b) M. Artico, S. Massa, A. Mai, M. E. Marongiu, G. Piras, E. Tramontano, P. La Colla, Antiviral Chem. Chemother. 1993, 4, 361-368;
- (1993) Antiviral Chem. Chemother , vol.4 , pp. 361-368
- Artico, M.¹ Massa, S.² Mai, A.³ Marongiu, M.E.⁴ Piras, G.⁵ Tramontano, E.⁶ La Colla, P.⁷

9
- 0028869436
- c) S. Massa, A. Mai, M. Artico, G. Sbardella, E. Tramontano, A. G. Loi, P. Scano, P. La Colla, Antiviral Chem. Chemother. 1995, 6, 1-8;
- (1995) Antiviral Chem. Chemother , vol.6 , pp. 1-8
- Massa, S.¹ Mai, A.² Artico, M.³ Sbardella, G.⁴ Tramontano, E.⁵ Loi, A.G.⁶ Scano, P.⁷ La Colla, P.⁸

10
- 0029095334
- d) A. Mai, M. Artico, G. Sbardella, S. Massa, A. G. Loi, E. Tramontano, P. Scano, P. La Colla, J. Med. Chem. 1995, 38, 3258-3263;
- (1995) J. Med. Chem , vol.38 , pp. 3258-3263
- Mai, A.¹ Artico, M.² Sbardella, G.³ Massa, S.⁴ Loi, A.G.⁵ Tramontano, E.⁶ Scano, P.⁷ La Colla, P.⁸

11
- 15444340492
- e) A. Mai, M. Artico, G. Sbardella, S. Quartarone, S. Massa, A. G. Loi, A. De Montis, F. Scintu, M. Putzolu, P. La Colla, J. Med. Chem. 1997, 40, 1447-1454;
- (1997) J. Med. Chem , vol.40 , pp. 1447-1454
- Mai, A.¹ Artico, M.² Sbardella, G.³ Quartarone, S.⁴ Massa, S.⁵ Loi, A.G.⁶ De Montis, A.⁷ Scintu, F.⁸ Putzolu, M.⁹ La Colla, P.¹⁰

12
- 0033602141
- f) A. Mai, M. Artico, G. Sbardella, S. Massa, E. Novellino, G. Greco, A. G. Loi, E. Tramontano, M. E. Marongiu, P. La Colla, J. Med. Chem. 1999, 42, 619-627;
- (1999) J. Med. Chem , vol.42 , pp. 619-627
- Mai, A.¹ Artico, M.² Sbardella, G.³ Massa, S.⁴ Novellino, E.⁵ Greco, G.⁶ Loi, A.G.⁷ Tramontano, E.⁸ Marongiu, M.E.⁹ La Colla, P.¹⁰

13
- 0035797356
- g) A. Mai, G. Sbardella, M. Artico, R. Ragno, S. Massa, E. Novellino, G. Greco, A. Lavecchia, C. Musiu, M. La Colla, C. Murgioni, P. La Colla, R. Loddo, J. Med. Chem. 2001, 44, 2544-2554;
- (2001) J. Med. Chem , vol.44 , pp. 2544-2554
- Mai, A.¹ Sbardella, G.² Artico, M.³ Ragno, R.⁴ Massa, S.⁵ Novellino, E.⁶ Greco, G.⁷ Lavecchia, A.⁸ Musiu, C.⁹ La Colla, M.¹⁰ Murgioni, C.¹¹ La Colla, P.¹² Loddo, R.¹³

14
- 10744230514
- h) R. Ragno, A. Mai, G. Sbardella, M. Artico, S. Massa, C. Musiu, M. Mura, T. Marceddu, A. Cadeddu, P. La Colla, J. Med. Chem. 2004, 47, 928-934;
- (2004) J. Med. Chem , vol.47 , pp. 928-934
- Ragno, R.¹ Mai, A.² Sbardella, G.³ Artico, M.⁴ Massa, S.⁵ Musiu, C.⁶ Mura, M.⁷ Marceddu, T.⁸ Cadeddu, A.⁹ La Colla, P.¹⁰

15
- 13844316071
- i) A. Mai, M. Artico, R. Ragno, G. Sbardella, S. Massa, C. Musiu, M. Mura, F. Marturana, A. Cadeddu, G. Maga, P. La Colla, Bioorg. Med. Chem. 2005, 13, 2065-2077.
- (2005) Bioorg. Med. Chem , vol.13 , pp. 2065-2077
- Mai, A.¹ Artico, M.² Ragno, R.³ Sbardella, G.⁴ Massa, S.⁵ Musiu, C.⁶ Mura, M.⁷ Marturana, F.⁸ Cadeddu, A.⁹ Maga, G.¹⁰ La Colla, P.¹¹

16
- 0031729622
- a) E. A. Sudbeck, C. Mao, R. Vig, T. K. Venkatachalam, L. Tuel-Ahlgren, F. M. Uckun, Antimicrob. Agents Chemother. 1998, 42, 3225-3233;
- (1998) Antimicrob. Agents Chemother , vol.42 , pp. 3225-3233
- Sudbeck, E.A.¹ Mao, C.² Vig, R.³ Venkatachalam, T.K.⁴ Tuel-Ahlgren, L.⁵ Uckun, F.M.⁶

17
- 0031942724
- b) K. Danel, E. B. Pedersen, C. Nielsen, J. Med. Chem. 1998, 41, 191-198;
- (1998) J. Med. Chem , vol.41 , pp. 191-198
- Danel, K.¹ Pedersen, E.B.² Nielsen, C.³

18
- 0032537520
- c) R. Vig, C. Mao, T. K. Venkatachalam, L. Tuel-Ahlgren, E. A. Sudbeck, F. M. Uckun, Bioorg. Med. Chem. Lett. 1998, 8, 1461-1466;
- (1998) Bioorg. Med. Chem. Lett , vol.8 , pp. 1461-1466
- Vig, R.¹ Mao, C.² Venkatachalam, T.K.³ Tuel-Ahlgren, L.⁴ Sudbeck, E.A.⁵ Uckun, F.M.⁶

19
- 2442610540
- d) Y. He F. Chen, G. Sun, Y. Wang, E. De Clercq, J. Balzarini, C. Pannecouque, Bioorg. Med. Chem. Lett. 2004, 14, 3173-3176;
- (2004) Bioorg. Med. Chem. Lett , vol.14 , pp. 3173-3176
- He, Y.¹ Chen, F.² Sun, G.³ Wang, Y.⁴ De Clercq, E.⁵ Balzarini, J.⁶ Pannecouque, C.⁷

20
- 13444263587
- e) V. Lather, A. K. Madan, Bioorg. Med. Chem. 2005, 13, 1599-1604.
- (2005) Bioorg. Med. Chem , vol.13 , pp. 1599-1604
- Lather, V.¹ Madan, A.K.²

21
- 27644505400
- Anti-HIV-1 activity was measured in lymphoid MT-4 cells by the colorimetric MTT assays as described on: M. Armand-Ugon, I. Clotet-Codina, C. Tintori, F. Manetti, B. Clotet, M. Botta, J. A. Este, Virology 2005, 343, 141-149.
- Anti-HIV-1 activity was measured in lymphoid MT-4 cells by the colorimetric MTT assays as described on: M. Armand-Ugon, I. Clotet-Codina, C. Tintori, F. Manetti, B. Clotet, M. Botta, J. A. Este, Virology 2005, 343, 141-149.

22
- 0031578901
- -1ol) and 2-4 nM RT in the presence of 8% final concentration of DMSO. All enzymes were purified to >95% purity.
- -1ol) and 2-4 nM RT in the presence of 8% final concentration of DMSO. All enzymes were purified to >95% purity.

23
- 54849409158
- Briefly, HIV-1 RT (20-40 nM, was incubated 2 min at 37°C in a final of 4 μL in the presence of 15 nM poly(rA)/oligo(dT, 3′-OH ends, reaction buffer, and 10 mM MgCl2. Inhibitor was then added to a final of 5 μL, the concentration at which the fraction of enzyme-inhibitor complex, defined as: [E:I, E0, 1-1/ (1+[I]/Ki, was >90, Then, 145 μL of a mix containing Buffer A, 10 mM MgCl2, and 10 μM [3H]-dTTP (1 Cimm-1ol) were added at different time points. After an additional 10 min of incubation at 37°C, 50 μL aliquots were spotted on GF/C filters and acid-precipitable radioactivity measured as described for the HIV-1 RT RNA-dependent DNA polymerase activity assay.[8] The quantity representing the normalized difference between the amount of dTTP incorporated at the zero time point and at the different time points, v 0
- on.

24
- 18844446685
- E. De Clercq, Expert Opin. Emerging Drugs 2005, 10, 241-273.
- (2005) Expert Opin. Emerging Drugs , vol.10 , pp. 241-273
- De Clercq, E.¹

25
- 54849426615
- i was used in the inhibition assays. Data were then plotted according to Lineweaver-Burke and Dixon.
- i was used in the inhibition assays. Data were then plotted according to Lineweaver-Burke and Dixon.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.